{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:42:08Z","timestamp":1780047728997,"version":"3.53.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.pscychresns.2008.01.004","type":"journal-article","created":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T08:26:24Z","timestamp":1224491184000},"page":"166-171","source":"Crossref","is-referenced-by-count":9,"title":["Positron emission tomography with fluorodeoxyglucose-F18 in an animal model of mania"],"prefix":"10.1016","volume":"164","author":[{"given":"Matthew Tyler","family":"Hougland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rif S.","family":"El-Mallakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2008.01.004_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1192\/bjp.169.4.509","article-title":"Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography","volume":"169","author":"Al-Mousawi","year":"1996","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.1985.01790280019002","article-title":"Cerebral metabolic rates for glucose in mood disorders","volume":"42","author":"Baxter","year":"1985","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-5618.2006.00310.x","article-title":"Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls","volume":"8","author":"Brooks","year":"2006","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-0327(86)90036-4","article-title":"Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness","volume":"10","author":"Buchsbaum","year":"1986","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3928\/0048-5713-19970701-10","article-title":"Neuroimaging bipolar illness with positron emission tomography and magnetic resonance imaging","volume":"27","author":"Buchsbaum","year":"1997","journal-title":"Psychiatric Annals"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0167-0115(88)90062-6","article-title":"Des-Leu angiotensin I: biosynthesis and drinking response","volume":"20","author":"Changaris","year":"1988","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib7","first-page":"4461","article-title":"Dynamic evaluation of [18F]-FDG uptake in the rate brain by microPET imaging","volume":"6","author":"Chen","year":"2004","journal-title":"Conference Proceedings of the International (IEEE) Conference of the Engineering in Medicine and Biology Society"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib9","series-title":"Lithium: Actions and Mechanisms","author":"El-Mallakh","year":"1996"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-3223(94)00201-D","article-title":"The Na,K-ATPase hypothesis for bipolar illness","volume":"37","author":"El-Mallakh","year":"1995","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0278-5846(95)00123-D","article-title":"An animal model for mania: preliminary results","volume":"19","author":"El-Mallakh","year":"1995","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1034\/j.1399-5618.2003.00053.x","article-title":"Intracerebroventricular administration of ouabain as a model of mania in rats","volume":"5","author":"El-Mallakh","year":"2003","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.pnpbp.2006.04.003","article-title":"Efficacy of olanzapine and haloperidol in an animal model of mania","volume":"30","author":"El Mallakh","year":"2006","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.biopsych.2005.12.021","article-title":"Involvement of Na(+),K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders","volume":"60","author":"Goldstein","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib15","series-title":"Manic-depressive Illness","author":"Goodwin","year":"1990"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0165-0327(98)00208-0","article-title":"Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls","volume":"54","author":"Grider","year":"1999","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.pscychresns.2008.01.004_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.neubiorev.2007.04.001","article-title":"Mimicking human bipolar ion dysregulation, models mania in rats","volume":"31","author":"Herman","year":"2007","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"Suppl. 3","key":"10.1016\/j.pscychresns.2008.01.004_bib18","first-page":"21","article-title":"Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies","volume":"63","author":"Ketter","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib19","first-page":"120","article-title":"Mood stabilizers and atypical antipsychotics: bimodal treatment for bipolar disorder","volume":"39","author":"Ketter","year":"2006","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-1781(87)90053-9","article-title":"11C-glucose metabolism in manic and depressed patients","volume":"22","author":"Kishimoto","year":"1987","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02815161","article-title":"Lithium prevents ouabain-induced behavioral changes: toward an animal model for manic-depression","volume":"31","author":"Li","year":"1997","journal-title":"Molecular Chemistry and Neuropathology"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1520-6394(1997)5:2<53::AID-DA1>3.0.CO;2-6","article-title":"Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness","volume":"5","author":"Looney","year":"1997","journal-title":"Depression and Anxiety"},{"issue":"2","key":"10.1016\/j.pscychresns.2008.01.004_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuroscience.2007.01.046","article-title":"Hyperbaric oxygen treatment attenuated the decrease in regional glucose metabolism of rats subjected to focal cerebral ischemia: a high resolution positron emission tomography study","volume":"146","author":"Lou","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pscychresns.2008.01.004_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nucmedbio.2005.09.003","article-title":"Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-D-glucose cerebral uptake in rodents through time","volume":"33","author":"Marsteller","year":"2006","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib25","series-title":"The Effect of Antimanic Drugs on the Hyperlocomotor Response to ICV Administration of Ouabain in the Rat","author":"Piper","year":"1996"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0006-3223(97)00440-X","article-title":"Alpha2 isoform of the Na,K-ATPase is reduced in temporal cortex of bipolar individuals","volume":"44","author":"Rose","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-9384(97)00457-5","article-title":"Persistent hyperactivity following a single intracerebroventricular dose of ouabain","volume":"63","author":"Ruktanochai","year":"1998","journal-title":"Physiology and Behavior;"},{"issue":"2","key":"10.1016\/j.pscychresns.2008.01.004_bib28","first-page":"277","article-title":"Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents","volume":"48","author":"Schiffer","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2008.01.004_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.2.5508.262","article-title":"Mineral metabolism, mania, and melancholia","volume":"2","author":"Shaw","year":"1966","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1016\/j.pscychresns.2008.01.004_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.106.036251","article-title":"Uptake of 18F-Fluorocholine, 18F-PET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis","volume":"48","author":"Wyss","year":"2007","journal-title":"Journal of Nuclear Medicine"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492708000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492708000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T00:27:08Z","timestamp":1545697628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492708000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0925492708000188"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2008.01.004","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}